HEADER OXIDOREDUCTASE 20-AUG-08 3E8O TITLE CRYSTAL STRUCTURE OF A PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE TITLE 2 (DR_2100) FROM DEINOCOCCUS RADIODURANS AT 1.40 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN WITH FERREDOXIN-LIKE FOLD; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DEINOCOCCUS RADIODURANS; SOURCE 3 ORGANISM_TAXID: 1299; SOURCE 4 GENE: NP_295823.1, DR_2100; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE, STRUCTURAL GENOMICS, KEYWDS 2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 24-JUL-19 3E8O 1 REMARK LINK REVDAT 4 25-OCT-17 3E8O 1 REMARK REVDAT 3 28-JUL-10 3E8O 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 3E8O 1 VERSN REVDAT 1 09-SEP-08 3E8O 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION WITH JRNL TITL 2 FERREDOXIN-LIKE FOLD (NP_295823.1) FROM DEINOCOCCUS JRNL TITL 3 RADIODURANS AT 1.40 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 35326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.130 REMARK 3 R VALUE (WORKING SET) : 0.128 REMARK 3 FREE R VALUE : 0.163 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1784 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2425 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.1790 REMARK 3 BIN FREE R VALUE SET COUNT : 126 REMARK 3 BIN FREE R VALUE : 0.2220 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1536 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.062 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.056 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.033 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.877 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.978 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.970 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1621 ; 0.017 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 996 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2218 ; 1.626 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2476 ; 1.747 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 217 ; 3.931 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 68 ;38.173 ;24.853 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 269 ;10.554 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ;25.585 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 268 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1823 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 295 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1029 ; 2.280 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 422 ; 1.177 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1651 ; 3.421 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 592 ; 4.674 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 559 ; 6.650 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2617 ; 1.974 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 289 ; 8.342 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2579 ; 4.568 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. EDO MOLECULE FROM THE CRYO SOLUTION IS MODELED. REMARK 3 4. AN UNKNOWN LIGAND (UNL) HAS BEEN MODELED IN THE PUTATIVE REMARK 3 ACTIVE SITE REMARK 4 REMARK 4 3E8O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000049014. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97916,0.97849 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35346 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 29.814 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M NAOAC, 30.0000% PEG-8000, 0.1M REMARK 280 CACODYLATE PH 6.5, VAPOR DIFFUSION,SITTING DROP,NANODROP, REMARK 280 TEMPERATURE 277K, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.81950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT CRYSTAL PACKING ANALYSIS SUGGESTS THE REMARK 300 ASSIGNMENT OF A DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 SER A 5 REMARK 465 MSE A 6 REMARK 465 LEU A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PRO A 10 REMARK 465 GLN A 11 REMARK 465 HIS A 12 REMARK 465 PRO A 13 REMARK 465 ARG A 14 REMARK 465 ARG A 15 REMARK 465 THR A 16 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 SER B 2 REMARK 465 PRO B 3 REMARK 465 GLN B 4 REMARK 465 SER B 5 REMARK 465 MSE B 6 REMARK 465 LEU B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PRO B 10 REMARK 465 GLN B 11 REMARK 465 HIS B 12 REMARK 465 PRO B 13 REMARK 465 ARG B 14 REMARK 465 ARG B 15 REMARK 465 THR B 16 REMARK 465 THR B 17 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 44 CG CD OE1 NE2 REMARK 470 GLU A 112 CG CD OE1 OE2 REMARK 470 GLN B 44 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 47 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 63 87.77 -156.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390777 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3E8O A 1 118 UNP Q9RSM4 Q9RSM4_DEIRA 1 118 DBREF 3E8O B 1 118 UNP Q9RSM4 Q9RSM4_DEIRA 1 118 SEQADV 3E8O GLY A 0 UNP Q9RSM4 LEADER SEQUENCE SEQADV 3E8O GLY B 0 UNP Q9RSM4 LEADER SEQUENCE SEQRES 1 A 119 GLY MSE SER PRO GLN SER MSE LEU THR SER PRO GLN HIS SEQRES 2 A 119 PRO ARG ARG THR THR MSE VAL ILE SER HIS GLY THR LEU SEQRES 3 A 119 SER ALA SER ALA GLU HIS ALA ALA HIS LEU ARG GLN LEU SEQRES 4 A 119 LEU VAL HIS ILE ALA GLN ALA THR ARG GLN GLU ASP GLY SEQRES 5 A 119 CYS LEU LEU TYR LEU VAL SER GLU ASP LEU SER GLN PRO SEQRES 6 A 119 GLY HIS PHE LEU ILE THR GLU HIS TRP ASP ASN LEU GLY SEQRES 7 A 119 ALA MSE HIS THR HIS LEU ALA LEU PRO GLY VAL THR GLN SEQRES 8 A 119 ALA ILE ASP ALA LEU LYS HIS LEU ASN VAL THR ASP LEU SEQRES 9 A 119 LYS ILE THR ALA TYR GLU ALA GLY GLU ALA ILE ASN ILE SEQRES 10 A 119 MSE GLY SEQRES 1 B 119 GLY MSE SER PRO GLN SER MSE LEU THR SER PRO GLN HIS SEQRES 2 B 119 PRO ARG ARG THR THR MSE VAL ILE SER HIS GLY THR LEU SEQRES 3 B 119 SER ALA SER ALA GLU HIS ALA ALA HIS LEU ARG GLN LEU SEQRES 4 B 119 LEU VAL HIS ILE ALA GLN ALA THR ARG GLN GLU ASP GLY SEQRES 5 B 119 CYS LEU LEU TYR LEU VAL SER GLU ASP LEU SER GLN PRO SEQRES 6 B 119 GLY HIS PHE LEU ILE THR GLU HIS TRP ASP ASN LEU GLY SEQRES 7 B 119 ALA MSE HIS THR HIS LEU ALA LEU PRO GLY VAL THR GLN SEQRES 8 B 119 ALA ILE ASP ALA LEU LYS HIS LEU ASN VAL THR ASP LEU SEQRES 9 B 119 LYS ILE THR ALA TYR GLU ALA GLY GLU ALA ILE ASN ILE SEQRES 10 B 119 MSE GLY MODRES 3E8O MSE A 18 MET SELENOMETHIONINE MODRES 3E8O MSE A 79 MET SELENOMETHIONINE MODRES 3E8O MSE A 117 MET SELENOMETHIONINE MODRES 3E8O MSE B 18 MET SELENOMETHIONINE MODRES 3E8O MSE B 79 MET SELENOMETHIONINE MODRES 3E8O MSE B 117 MET SELENOMETHIONINE HET MSE A 18 13 HET MSE A 79 8 HET MSE A 117 13 HET MSE B 18 8 HET MSE B 79 8 HET MSE B 117 13 HET UNL A 200 6 HET UNL B 200 6 HET EDO B 201 4 HETNAM MSE SELENOMETHIONINE HETNAM UNL UNKNOWN LIGAND HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *271(H2 O) HELIX 1 1 HIS A 31 ARG A 47 1 17 HELIX 2 2 ASN A 75 ALA A 84 1 10 HELIX 3 3 LEU A 85 LEU A 98 1 14 HELIX 4 4 SER B 28 ARG B 47 1 20 HELIX 5 5 ASN B 75 ALA B 84 1 10 HELIX 6 6 LEU B 85 HIS B 97 1 13 SHEET 1 A10 ILE A 114 MSE A 117 0 SHEET 2 A10 LYS B 104 GLU B 109 -1 O ALA B 107 N ILE A 114 SHEET 3 A10 VAL B 19 SER B 26 -1 N ILE B 20 O TYR B 108 SHEET 4 A10 HIS B 66 TRP B 73 -1 O PHE B 67 N LEU B 25 SHEET 5 A10 CYS B 52 ASP B 60 -1 N LEU B 56 O THR B 70 SHEET 6 A10 CYS A 52 ASP A 60 -1 N GLU A 59 O GLU B 59 SHEET 7 A10 HIS A 66 TRP A 73 -1 O HIS A 66 N ASP A 60 SHEET 8 A10 VAL A 19 SER A 26 -1 N LEU A 25 O PHE A 67 SHEET 9 A10 LYS A 104 GLU A 109 -1 O TYR A 108 N ILE A 20 SHEET 10 A10 ILE B 114 MSE B 117 -1 O MSE B 117 N ILE A 105 LINK C THR A 17 N MSE A 18 1555 1555 1.34 LINK C MSE A 18 N VAL A 19 1555 1555 1.31 LINK C ALA A 78 N MSE A 79 1555 1555 1.32 LINK C MSE A 79 N HIS A 80 1555 1555 1.32 LINK C ILE A 116 N MSE A 117 1555 1555 1.31 LINK C MSE A 117 N GLY A 118 1555 1555 1.33 LINK C MSE B 18 N VAL B 19 1555 1555 1.32 LINK C ALA B 78 N MSE B 79 1555 1555 1.33 LINK C MSE B 79 N HIS B 80 1555 1555 1.33 LINK C ILE B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N GLY B 118 1555 1555 1.33 SITE 1 AC1 5 TYR A 55 GLU A 71 HIS A 82 ILE A 105 SITE 2 AC1 5 HOH A 231 SITE 1 AC2 6 ILE B 42 TYR B 55 GLU B 71 HIS B 82 SITE 2 AC2 6 ILE B 105 HOH B 225 SITE 1 AC3 7 THR B 24 ASP B 60 HIS B 66 PHE B 67 SITE 2 AC3 7 LEU B 68 HOH B 324 HOH B 330 CRYST1 33.715 59.639 47.511 90.00 97.18 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029660 0.000000 0.003735 0.00000 SCALE2 0.000000 0.016767 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021214 0.00000 MASTER 353 0 9 6 10 0 6 6 0 0 0 20 END